City

San Francisco (2)

Condition

Locally Advanced Malignant Solid Neoplasm (2)

Metastatic Malignant Solid Neoplasm (2)

Advanced Malignant Solid Neoplasm (1)

HPV-Related Squamous Cell Carcinoma (1)

Human Papillomavirus-Related Carcinoma (1)

Human Papillomavirus-Related Squamous Cell Carcinoma (1)

PIK3CA Mutation (1)

PIK3CA Mutation-Related Tumors (1)

Solid Tumors, Adult (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Phase

n/a (1)

phase 1 (1)

Sponsor

Pamela Munster (1)

University of California, San Francisco (1)

Collaborator

Novartis (1)

Intervention

alpelisib (1)

carboplatin (1)

continuous glucose monitor (cgm) (1)

hyperpolarized carbon-13 (13c) pyruvate (1)

interview (1)

quality of life (qol) questionnaires (1)

support group therapy (1)

symptom management service (sms) consultation (1)

Study Documents

Intervention Type

behavioral (1)

device (1)

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

locally advanced malignant solid neoplasm

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,

Not yet recruiting

Solid Tumors, Adult
+7 more

Alpelisib
+3 more

San Francisco, California

University of California, San Francisco

Jul 21, 2022

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in San Francisco

Recruiting

Advanced Malignant Solid Neoplasm
+2 more

Support Group Therapy
+3 more

San Francisco, California

University of California, San Francisco

May 12, 2022